Serotonin Syndrome Market Players, Drivers, Opportunities and Forecast Analysis to 2030

 Serotonin Syndrome Market

The serotonin syndrome market report is an informative and in-depth analysis that offers a detailed overview of the industry, including recent developments and potential proportions of the demand for serotonin syndrome in terms of products and services. 

The Serotonin Syndrome Market is expected to reach USD 692.2 Million by 2030 at 4.8% CAGR during the forecast period 2022-2030.

Serotonin syndrome is a group of symptoms such as high body temperature, increased reflexes, anxiety, tremor, sweating, diarrhea, dilated pupils, etc. due to the use of serotonergic drugs. Severe complications, such as seizures and extensive muscle breakdown, can lead to death. The case of Libby Zion in 1984 is an example of death from serotonin syndrome. Serotonin syndrome is usually caused by a synergistic effect of two or more serotonergic drugs, commonly including serotonin norepinephrine reuptake inhibitor (SNRI), selective serotonin reuptake inhibitor (SSRI), monoamine oxidase inhibitor (MAOI), tricyclic antidepressants (TCAs), amphetamines, etc. Many drugs with a high potential to induce serotonin syndrome include dextromethorphan, buspirone, L-tryptophan, St. John's wort, metoclopramide, ondansetron, etc. There is no laboratory test supporting the diagnosis of serotonin syndrome.

Market Dynamics

Treatment for serotonin syndrome requires the discontinuation of medications that lead to the disorder. Many treatments for treating related symptoms can be used in severe cases. For severe cases with life-threatening gastrointestinal decontamination, using activated charcoal is performed. Sedatives such as benzodiazepines are used in agitated patients. High fever is a typical symptom of serotonin syndrome that reaches exceptionally high temperatures of more than 40 centigrade. Cooling measures can be required to regulate hyperthermia. Serotonin antagonist, such as cyproheptadine, may be necessary.

Market restraints on serotonin syndrome are the low number of cases and the equally small number of fatalities associated with serotonin syndrome in less than 1 % of cases of serotonin syndrome caused by disease-causing medications. Mild symptoms occur in approximately 15% of SSRI overdoses.

Major Key Players:

global Serotonin Syndrome Market Players are Johnson & Johnson, AstraZeneca Plc., Eli Lilly and Company, Forest Laboratories Inc., Ciron Drugs & Pharmaceuticals Pvt. Ltd, GlaxoSmithKline plc., Merck & Co., Inc., Pfizer, Inc. and Sanofi S.A, and others.

Segment Analysis

The global market for serotonin syndrome is segmented on serotonin syndrome treatment and end-users. 

Based on drug treatment, the market for serotonin syndrome has been segmented as serotonin antagonists, supportive care(anti-hyperthermics, Muscle relaxants, the control of autonomic instability, antihypertensive, and others).

 Based on the end-users, the market has been segmented as hospitals, point of care, and others.

Regional Analysis

The global serotonin syndrome market is segmented into North America, Europe, the Asia Pacific, and the Middle East & Africa.

North America is further segmented into the United States and Canada. The United States accounts for the highest market share due to the increased use of medicines and higher expenditure on healthcare. The rapid consumer adoption of emerging technology and devices in the United States is also an essential factor driving the global market for serotonin syndrome. 

Europe is the second-largest market due to high disposable incomes and increased awareness. 

The Asia Pacific region is projected to have the most potential for the future and is predicted to be led by China and India. 

The Middle East & Africa market is dominated by Gulf nations, especially Saudi Arabia and the UAE. Africa's regions are projected to experience modest growth due to weak economic,  political conditions, and low healthcare penetration.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Varicocele Treatment Market Analysis, Trends and Opportunities 2022 - 2030

Varicocele Treatment Market

The global Varicocele Treatment Market has been evaluated as a moderately growing market and it is expected to continue growing in the near future. Varicocele is an enlargement of the veins within the scrotum, the scrotum is a skin-covered loose bag that holds testicles. Increasing number of varicocele, availability of effective treatments, and increasing awareness are leading the growth for the market. The other. Advanced diagnostics and treatment are key factors for the market growth. The increasing demand from emerging economies of Asia are driving the growth for the market. Hospitals, researchers and academic institutes are continuously doing research to derive effective cure for varicocele that is another important factor for the growth of global Varicocele Treatment Market.

The Varicocele Treatment Market is anticipated to reach USD 545.45 million by 2030 at 6.40% CAGR during the forecast period 2022-2030.

Taste the market data and market information presented through more than 54 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Varicocele Treatment Market Research Report–Global Forecast.”

Major Key Players:

There are plenty of large and small Varicocele treatment Market Players which operate in this market: Bayer (Germany), Depomed, Inc. (US), GlaxoSmithKline plc. (UK), INSYS THERAPEUTICS, INC. (US), Janssen Global Services, LLC (Belgium) Mylan N.V. (US), Novartis AG (Switzerland), PurduePharma (US), Pfizer Inc. (US), and others

Market Segmentation

Global varicocele surgery market has been segmented on the basis of grade which comprise grade I, grade II, grade III, and others.

On the basis of diagnosis it is segmented into physical exam, imaging test, and others. Imaging test further sub-segmented into thermography, scrotal ultrasound, and others

On the basis of treatments, the market has been segmented into varicocele repair, varicocele embolization, medication, and others. Varicocele repair is sub-segmented into open surgery, laparoscopic surgery, percutaneous embolization, and others. Medication is sub-segmented into painkillers, and others. Painkillers includes acetaminophen, ibuprofen, and others.

On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.

Regional Analysis

Considering the global scenario of the Varicocele Treatment Market, there are four main regions- America, Europe, Asia Pacific, and Middle East & Africa. The Americas are holding largest market share. The Americas mainly include North America and Latin America. North America is largest and top revenue generator market for varicocele treatment. Europe is second largest market. Germany, UK, and France are the major markets while Eastern European Varicocele Treatment Market is also growing. Asia Pacific varicocele treatment is also growing significantly. Some major factors like increasing awareness of the disease, developing healthcare sector, and rising healthcare expenditure are driving the growth for Asia Pacific Varicocele Treatment Market. Middle East & Africa Varicocele Treatment Market is expected to have limited growth mainly due to lack of knowledge of the disorder, and limited access to the healthcare facilities. Due to developed healthcare infrastructure and high expenditure on healthcare, Middle East is dominating region as compared to Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pregnancy Test Kits Market Players, Regional Analysis and Growth Forecast to 2030

Pregnancy Test Kits Market

The pregnancy test kits market size is expected to reach USD 1.94 billion by 2030 at 5.17% CAGR during the forecast period 2022-2030

The Pregnancy test kits market has been evaluated as average growing market and expected that the market will reach high growth figures in coming years. A factsheet published by the WHO states that about 40% of pregnancy cases reported each year were unintended and around 10% cases were that of teenage pregnancies and the number is expected to increase further in the coming years. These are the main reasons leading to the market growth of pregnancy test kits market. Other factors such as the increasing awareness about the availability of pregnancy test kits with their clinically proven safety and effectiveness has resulted in an increasing demand for self-detecting pregnancy kits thereby increasing the growth and size of global pregnancy test kits market. Moreover, the escalating adolescent pregnancy rate, promotional campaigns undertaken by manufacturers of these pregnancy test or recognition kits is driving the growth of pregnancy test kits market.

North America holds the first rank in global pregnancy test kit market during the forecasted period. The market in the region is likely to elaborate at a CAGR of 3.8% over the next few years. Higher expenditure on healthcare sector is expected to be a major growth driver of North America pregnancy test kit market. Western Europe pregnancy test kit market is also anticipated to witness a promising growth sparked by rising adoption of digital pregnancy test kit devices in the region. Asia-Pacific pregnancy test kit market is expected to observe a highest CAGR during the forecast period. Speedily expanding population in the region, rising per capita pay and growing urbanization are some of the major issues which are projected to strengthen pregnancy test kit market in countries such as India and China.

Major Key Players:

The Pregnancy Test Kits Market Players are Alere Inc. (US), Prestige Brands Holdings, Inc, (US), Quidel Corporation (US), Procter & Gamble Co., (Germany), Piramal Enterprises (India), Cardinal Health (US), and Confirm Biosciences (US).

Market Segmentation

The global pregnancy kits market is segmented on the basis of type of test, product and end users. Based on the type of test, the market has been segmented as blood test for HCG, Urine test for HCG and others. Based on products, the market has been segmented into digital devices, line indicators which are further segmented into strips, cassettes and mid-stream devices and others. Further on the basis of end users the market has been segmented as hospitals, clinics, households and others. The home pregnancy test segment is growing at a rapid pace due to technological progressions and arresting product features with major organizations such as Alere Inc, Prestige Brands Holding Inc, and Procter & Gamble etc playing the key role in the launching of new and innovative home pregnancy test kits. Also the market has been growing due to the reasons such as some of the home pregnancy test kits have 99% exactness rate in detecting HCG levels from the day of the expected period of women undertaking the test. The HCG urine test accounts for the largest pregnancy test market share as per alleged pregnancy test market capturing nearly 43% of the revenues shared in 2016. There is an increasing inclination for conventional laboratory tests resulting in the decline of other test types such as FSH Urine test, HCG blood test, and LH urine test.

Regional Analysis

The regional segmentation of the global pregnancy test strips market North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). The lion's share in this market belongs to North America, and this share is expected to grow during the forecast period. Reasons for the growth of this market include increasing pool of aware females, need for household determination of pregnancy, and investment regarding the advancement of pregnancy test kits. Biggest share in the North American market is controlled by the United States of America (USA). Many key players in this market are also based in the USA.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Saudi Arabia Medical Devices Market Players, Opportunities, Trends, Analysis and forecast to 2030

Saudi Arabia Medical Devices Market

A medical device is any instrument, appliance including any software, biologic or non-biologic material, to be used for the diagnostic or therapeutic use for management of diseases and disorders.

Saudi Arabia Medical Devices Market is anticipated to reach USD 3,100 Million by 2030 at 5.80% CAGR during the forecast period 2022-2030

The medical device industry witnessed one of the fastest growth propelled by innovation and rapid uptake of technologies. The medical devices industry has also resulted in the successful fusion of information technology and healthcare. Technology and product development remain the main pillars for the growing market for medical devices. The market involves two segments one high-tech devices with extreme sophistication and another is the low tech improved devices. The high tech segment such as diagnostic imaging devices is witnessing higher rates of growth. The low tech segment is also growing at a good rate but has witnessed growth in developing regions as the market for these in developed regions is stagnant. The other market driving factors are rising public healthcare expenditure in Saudi Arabia, development of large hospitals such as King Faisal hospital in Riyadh, demand for noninvasive therapy etc.

The market constraints are strict and ambiguous regulatory framework, growing concern for security especially data security, differential availability between developed and developing regions, connectivity issues in Saudi Arabia, the interference Sharia courts etc.

The future developments will include cloud integration, connected healthcare devices and growing demand for personalized medical wearable devices. Healthcare mobile applications will also lead the market.

Major Key Players:

The Saudi Arabia Medical Devices Market Players are: Johnson & Johnson, General Electric, Medtronic, Koninklijke Philips Electronics NV., Baxter Internationa, Fresenius Medical Care AG & Co., Cardinal Health, Al-Salehiya Medical Estableshment, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Al Amin Medical Instruments Company (AMICO), Al Faisaliah Medical Systems (FMS), Siemens Ltd and others.

Market Segmentation

Saudi Arabia medical devices market has been segmented on the basis of product type which comprises monitoring devices, diagnostic devices, diagnostic molecular devices, drug delivery devices, surgical devices, bio implants and stimulation devices, automation and robotics, electromedical devices and others. On the basis of therapeutic application; market is segmented into general surgery, diagnostic imaging, respiratory, orthopedics, cardiovascular, dental, neurology, ophthalmology, ear-nose-throat (ENT), nephrology and urology, and others. On the basis of end users; market is segmented hospitals, ambulatory, home and others.

Regional Analysis

The healthcare sector of Saudi Arabia is divided between private and state. The public healthcare expenditure accounts for approximately 75% of total health expenditure in 2014. Local manufacturing represents a poor outlook which is limited to consumables and ordinary articles. The government has established some of the best hospitals in the region such as King Faisal specialist hospital and research center, Riyadh military hospital, Saudi Arabia’s National Guard health affairs hospital etc. Saudi Arabia is extremely dependent on imports for medical devices and imports account for approximately 92% of total market for medical devices. U.S. medical device suppliers dominate the scenario with European vendors in the second position. Among the regions of Saudi Arabia Riyadh tops the healthcare expenditure list followed by Tabuk, Makkah and Madina. 

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Oral Mucositis Market Regional Analysis, Key Players, Opportunities and Forecast to 2030

Oral Mucositis Market

The oral mucositis market is expected to reach USD 890 million by 2030 at 7.8% CAGR during the forecast period 2022-2030

Prevalence of chronic disease such as cancer has multifarious effects on the human body. One such is oral mucositis where individuals suffer from painful lesions of the mucous membranes. This can be seen as a side-effect of the chemotherapy, and it is proportional to the growth of the chemotherapy dose. The disease can adversely affect an individual’s nutritional habits as it prevents the patient from chewing solid foods and even at times, from swallowing it. Among chief drivers, recently patented drugs for oral mucositis are playing significant roles. Furthermore, several investments in research and development are also ensuring considerable market growth.

However, most of the medicines are costly, and some await clinical trial and license. This could deter the expected market growth during the forecast period.

Major Key Players:

Some of Oral Mucositis Market Players are Izun Pharmaceutical Ltd (US), Shoreline Pharmaceuticals Inc. (USA), Himalaya (India), AMAG Pharmaceuticals Inc. (USA), Kinnear Pharmaceuticals (US), Celleutix Corporation (USA), Soligenix Inc. (US), Oragenics (US), and others.  

Market Segmentation

The global oral mucositis market can be segmented by cause and end-users.

Based on cause, the oral mucositis market includes oral mucositis caused by mucositis chemotherapy, oral mucositis caused by radiotherapy, and hematopoietic stem cell transplantation.

Based on end-users, the oral mucositis market includes hospitals, dental clinics, oncology hospitals, and research institutes.

Regional Analysis

Based on the global coverage, the oral mucositis market can be analyzed keeping up with the following regions: the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

By gaining tailwind from the presence of major brands with FDA approved drugs and superior infrastructure, the Americas are driving the market forward. Furthermore, massive investment in the healthcare sector, coupled with well-planned reimbursement policies, is giving the market further thrust.

Europe is enjoying similar kind of benefits and is spending much on research and development to gain the upper hand in its battle against oral mucositis. Meanwhile, the APAC is registering substantial growth owing to its impressive revamping of the healthcare sector. Better infrastructure in emerging economies such as India and China can prove beneficial for the market. However, the MEA market is lagging behind. Its poor infrastructure has put a leash on the regional market growth.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Cervical Dystonia Market 2022 Size, Share, Growth, Opportunities and forecast to 2030

Cervical Dystonia Market

Cervical dystonia is a neurological movement disorder associated with involuntary movement of neck. It is also known as spasmodic torticollis. As per study it was estimated that women are more prone to get this disorder.

The Cervical Dystonia Market is anticipated to reach USD 384.6 Million by 2030 at 7.3% CAGR during the forecast period 2022-2030.

The growth of the market is mainly due to increase in prevalence of Parkinson’s disease, development of new drugs and therapies by players, and greater involvement of the companies in research and development. Besides that, current unmet needs for the cervical dystonia also presents great opportunities for the market players to enter into this market.

That being said, there are few hurdles in the growth of this market such as high cost involved in the research and development leading to the increased cost of the drug, less awareness about the severity of the condition in developing and under developed regions. These factors hinder the cervical dystonia market growth. Global cervical dystonia market is expected to grow at a CAGR of 7.3% during forecasted period.

Experts say, exciting times are ahead for the cervical dystonia market, as the market events noted above are due to occur against the backdrop of a steadily growing cervical dystonia prevalent population. With the clinical unmet need for better diagnostic tools and treatment options for the affected population, cervical dystonia remains an attractive neurological disorder for drug developers.

Major Key Players:

The global Cervical Dystonia Market Players such as ALLERGAN (Ireland), Solstice Neurosciences LLC (U.S.), Ipsen Biopharmaceuticals Inc. (France), Merz Inc (U.S.), US WorldMeds, LLC (U.S.) Addex Therapeutics (Switzerland), Revance Therapeutics, Inc.(U.S.), and many other. These are some of the prominent players at the forefront of competition in the global cervical dystonia market and are profiled in MRFR Analysis report.

Market Segmentation

Global cervical dystonia market has been segmented on the basis of type which includes torticollis, retrocollis, laterocollis and others.  On the basis of treatment they are segmented into oral therapy, intravenous, surgery and other. On the basis of end user they are segmented into hospital, clinics and other. On the basis of type torticollis is the occurring type of this disease which is followed by laterocollis.

Regional Analysis

Americas has the largest cervical dystonia treatment. Increasing people suffering from cervical dystonia in America has help to increase the market in this region. Beside this, rise in neurotoxin market, increase in treatments for muscle movement disorders and increasing aging population in this region has fuelled the growth of this market in American region. Due to a huge aging population in Canada the market is developing at a significant rate in this region. As per study, women are more prone to cervical dystonia than men.

Europe has the second largest market which majorly contributed by UK, Germany and France. Well-developed healthcare sector, improved infrastructure and increase in healthcare spending have increased the market in this region.

Asia Pacific is expected to be the fastest growing region for the cervical dystonia market. Asia Pacific is the developing region and a huge population base in this region is the major factor for the growth of the market. Beside this continuous development in healthcare sector and increasing aging population in Asia Pacific has provided fuel for the growth of the market. India and China are the major market of the cervical dystonia.  Due to less development in medical and healthcare sector, Middle East and Africa region contributes least in the cervical dystonia market at present.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Human Genetics Market Players, Trends, Segmentation Analysis and Forecast to 2027

Human Genetics Market

Human genetics is the broad field of studying human inheritance and comprises sub-sections such as cytogenetics, molecular genetics, genetic counseling, clinical genetics, and others. It helps to understand gene functionalities and the consequences of abnormalities in them. Through human genetics, the human genome is studied to diagnose genetic disorders and provide related treatment much more efficiently.

The global human genetics market is expected to have a market value of USD 1,12,536.54 million by 2027.The growth of human genetics is driven by the growing adoption of genetic testing. However, high cost of genetic testing is likely to restrain the market growth.  

Major Key Players:

MRFR recognizes Human Genetics Market Players are— Myriad Genetics (US), Synlab Group (Germany), Eurofins Megalab S.A (Spain), Biomarker Technology (US), Echevarne Laboratory (Spain), Elabscience Biotechnology Inc (US), NIMGenetics (Spain), Sistemas Genómicos (Spain), FullGenomics (Spain), GENinCode (UK), Atrys Health (Spain), Genyca (Spain), Igenomix (India), Genologica (Spain), Bode Technology Group Inc (US).

Key Findings of the Study

US accounted for the largest share of the global human genetics market due to the increasing demand for genetic testing by the population are driving the market in the region. For instance, according to Healthline Media (US), in October 2019, United HealthCare Services, Inc. (US), the largest health insurance company in the US, started providing insurance coverage for multi-panel genetic testing. According to the National Institutes of Health (NIH), in July 2022, over 77,000 genetic tests are currently used in the US, and more are under development.

Regional Analysis

The global human molecular genetics market, based on region, has been divided into US, Canada, UK, Germany, Spain, Japan, others.

The human genetics market in the US benefits from a high healthcare expenditure, increasing demand for genetic testing by the population, and high public awareness regarding early detection of diseases and preventive care. Moreover, the availability of reimbursements in the US for genetic tests further improves market growth in the country. For instance, in October 2019, United HealthCare Services, Inc. (US), the largest health insurance company in the US, started providing insurance coverage for multi-panel genetic testing. According to the National Institutes of Health (NIH), in July 2022, over 77,000 genetic tests are currently used in the US, and more are under development.

Public-funded genetic testing in Canada is highly restricted and is only available to a select few who fall into certain criteria, such as a family history of cancer and early onset of cancer. Additionally, people in Canada who want their genetic testing done can opt for direct-to-consumer genetic tests such as color and invitae. Results from these tests can then be consulted with genetic counselors. Furthermore, there are human genetics programs to test patients with genetic disorders across Canada. For instance, the Hereditary Cancer Program is based in British Columbia, Canada, conducting genetic counseling and tests to detect hereditary cancer.

Clinically directed genetic testing has been available for several decades in the NHS for predictive testing for family members and molecular genetic investigation of a clinical presentation. Genomic health data in the UK is generated in three major areas, including large-scale research programs, the healthcare system, and purchasing of direct-to-consumer genetic testing. Moreover, the rise in the number of initiatives undertaken by the public as well as private organizations is further aiding the market growth. For instance, in April 2022, GEN inCode UK Limited announced its collaboration with Royal Brompton and Harefield hospitals (RB&H) for providing cardiovascular disease clinical genetic testing and reporting. In August 2022, DnaNudge announced the completion of its Series A investment round of USD 60 million led by Ventura Capital

The rising prevalence of genetic disorders, cancer, increasing awareness and acceptance regarding personalized medicines, and growing focus on R&D activities contribute to the country's growth. As per the data published by Global Cancer Observatory in March 2022, cancer accounted for 628,516 new cases and 252,065 deaths in Germany in 2022. In addition, the government is implementing a number of favorable and collaborative policies to incorporate genetic testing into the healthcare system and provide insurance reimbursements to citizens, which, in turn, is driving the market growth.

Segmentation

The global human genetics market is segmented into application, end user and region. The application segment is further segmented into wellness & E-commerce, preventive medicine, diagnostic & treatment. The diagnostic & treatment segment is further sub-segmented into oncology, cardiology, assisted reproduction, neurology, gynecology, others. The neurology segment is further sub-segmented into neuropediatric, others. The test segment is further segmented into NIPT, carrier testing, pharmacogenomic testing, karyotype testing, thrombophilia testing, septin 9 biomarker testing, NGS, others. The NGS segment is further sub-segmented into oncology, cardiology, others.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pregnancy Test Kits Market 2022: Size, Share, Drivers, Restraints, Analysis and Forecast-2030

 Pregnancy Test Kits Market

The pregnancy test kits market size is expected to reach USD 1.94 billion by 2030 at 5.17% CAGR during the forecast period 2022-2030

The Pregnancy test kits market has been evaluated as average growing market and expected that the market will reach high growth figures in coming years. A factsheet published by the WHO states that about 40% of pregnancy cases reported each year were unintended and around 10% cases were that of teenage pregnancies and the number is expected to increase further in the coming years. These are the main reasons leading to the market growth of pregnancy test kits market. Other factors such as the increasing awareness about the availability of pregnancy test kits with their clinically proven safety and effectiveness has resulted in an increasing demand for self-detecting pregnancy kits thereby increasing the growth and size of global pregnancy test kits market. Moreover, the escalating adolescent pregnancy rate, promotional campaigns undertaken by manufacturers of these pregnancy test or recognition kits is driving the growth of pregnancy test kits market.

North America holds the first rank in global pregnancy test kit market during the forecasted period. The market in the region is likely to elaborate at a CAGR of 3.8% over the next few years. Higher expenditure on healthcare sector is expected to be a major growth driver of North America pregnancy test kit market. Western Europe pregnancy test kit market is also anticipated to witness a promising growth sparked by rising adoption of digital pregnancy test kit devices in the region. Asia-Pacific pregnancy test kit market is expected to observe a highest CAGR during the forecast period. Speedily expanding population in the region, rising per capita pay and growing urbanization are some of the major issues which are projected to strengthen pregnancy test kit market in countries such as India and China.

Major Key Players:

Key players profiled in the report are Alere Inc. (US), Prestige Brands Holdings, Inc, (US), Quidel Corporation (US), Procter & Gamble Co., (Germany), Piramal Enterprises (India), Cardinal Health (US), and Confirm Biosciences (US).

Market Segmentation

The global pregnancy kits market is segmented on the basis of type of test, product and end users. Based on the type of test, the market has been segmented as blood test for HCG, Urine test for HCG and others. Based on products, the market has been segmented into digital devices, line indicators which are further segmented into strips, cassettes and mid-stream devices and others. Further on the basis of end users the market has been segmented as hospitals, clinics, households and others. The home pregnancy test segment is growing at a rapid pace due to technological progressions and arresting product features with major organizations such as Alere Inc, Prestige Brands Holding Inc, and Procter & Gamble etc playing the key role in the launching of new and innovative home pregnancy test kits. Also the market has been growing due to the reasons such as some of the home pregnancy test kits have 99% exactness rate in detecting HCG levels from the day of the expected period of women undertaking the test. The HCG urine test accounts for the largest pregnancy test market share as per alleged pregnancy test market capturing nearly 43% of the revenues shared in 2016. There is an increasing inclination for conventional laboratory tests resulting in the decline of other test types such as FSH Urine test, HCG blood test, and LH urine test.

Regional Analysis

The regional segmentation of the global pregnancy test strips market North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). The lion's share in this market belongs to North America, and this share is expected to grow during the forecast period. Reasons for the growth of this market include increasing pool of aware females, need for household determination of pregnancy, and investment regarding the advancement of pregnancy test kits. Biggest share in the North American market is controlled by the United States of America (USA). Many key players in this market are also based in the USA.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Saudi Arabia Medical Devices Market, Size, Share, Growth, Business Risk & Industry Analysis Reports 2030

 Saudi Arabia Medical Devices Market

A medical device is any instrument, appliance including any software, biologic or non-biologic material, to be used for the diagnostic or therapeutic use for management of diseases and disorders.

Saudi Arabia Medical Devices Market is anticipated to reach USD 3,100 Million by 2030 at 5.80% CAGR during the forecast period 2022-2030

The medical device industry witnessed one of the fastest growth propelled by innovation and rapid uptake of technologies. The medical devices industry has also resulted in the successful fusion of information technology and healthcare. Technology and product development remain the main pillars for the growing market for medical devices. The market involves two segments one high-tech devices with extreme sophistication and another is the low tech improved devices. The high tech segment such as diagnostic imaging devices is witnessing higher rates of growth. The low tech segment is also growing at a good rate but has witnessed growth in developing regions as the market for these in developed regions is stagnant. The other market driving factors are rising public healthcare expenditure in Saudi Arabia, development of large hospitals such as King Faisal hospital in Riyadh, demand for noninvasive therapy etc.

The market constraints are strict and ambiguous regulatory framework, growing concern for security especially data security, differential availability between developed and developing regions, connectivity issues in Saudi Arabia, the interference Sharia courts etc.

The future developments will include cloud integration, connected healthcare devices and growing demand for personalized medical wearable devices. Healthcare mobile applications will also lead the market.

Major Key Players:

The major participants of this market are: Johnson & Johnson, General Electric, Medtronic, Koninklijke Philips Electronics NV., Baxter Internationa, Fresenius Medical Care AG & Co., Cardinal Health, Al-Salehiya Medical Estableshment, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Al Amin Medical Instruments Company (AMICO), Al Faisaliah Medical Systems (FMS), Siemens Ltd and others.

Market Segmentation

Saudi Arabia medical devices market has been segmented on the basis of product type which comprises monitoring devices, diagnostic devices, diagnostic molecular devices, drug delivery devices, surgical devices, bio implants and stimulation devices, automation and robotics, electromedical devices and others. On the basis of therapeutic application; market is segmented into general surgery, diagnostic imaging, respiratory, orthopedics, cardiovascular, dental, neurology, ophthalmology, ear-nose-throat (ENT), nephrology and urology, and others. On the basis of end users; market is segmented hospitals, ambulatory, home and others.

Regional Analysis

The healthcare sector of Saudi Arabia is divided between private and state. The public healthcare expenditure accounts for approximately 75% of total health expenditure in 2014. Local manufacturing represents a poor outlook which is limited to consumables and ordinary articles. The government has established some of the best hospitals in the region such as King Faisal specialist hospital and research center, Riyadh military hospital, Saudi Arabia’s National Guard health affairs hospital etc. Saudi Arabia is extremely dependent on imports for medical devices and imports account for approximately 92% of total market for medical devices. U.S. medical device suppliers dominate the scenario with European vendors in the second position. Among the regions of Saudi Arabia Riyadh tops the healthcare expenditure list followed by Tabuk, Makkah and Madina. 

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Antipsychotic Drugs Market report predicts impressive growth by 2030 just published

 Antipsychotic Drugs Market

Anti-psychotics are drugs used in the treatment of psychosis which are a group of disorders characterized by serious distortion of thought, behavior, recognition of reality and perception, delusions and hallucinations.

Antipsychotic Drugs Market is expected to register a CAGR of 5.7% to reach USD 33.59 Billion by 2030

The market for psychotics represents a huge potential as can be seen from the following estimates by World Health Organization (WHO)

Depression affects an estimated 300 million people in the world.

Bipolar affective disorder takes a toll on about 60 million people worldwide.

Schizophrenia, a severe mental disorder, affects about 21 million people worldwide.

Dementia has a prevalence in about 47.5 million people worldwide

One fourth of people are affected by mental or neurological disorders at some point in their lives.

Thus the current number of untapped patients are of an order of around 450 million. Other market drivers are growing awareness and focus on mental illness, inclusion of more conditions such as learning disability in the mental disorders segment, rise of geriatrics population and mental hospitals etc.

The market constraints are social stigma and discrimination, poor efficacy and efficiency of anti-psychotic drugs, serious side effects such as habit forming potential etc. Patent expiry is also constraining the market as a number of established brands such as, Zyprexa, Seroquel, Risperdal lost patents. The drug development pipeline represents another miserable situation. The development pipeline is poor with a few if any novel acting drugs. The market represents numerous drugs with same mechanism of action and similar therapeutic profile which has hampered the market. Strict regulatory framework is another barrier along with the technical difficulties with performing clinical trials for these class of drugs as it is difficult to separate cause and effect in case of anti-psychotic drugs.

Major Key Players:

The major participants of this market are: Eli Lilly & Co., Bristol-Myers Squibb, AstraZeneca, Pfizer Inc., GlaxoSmithKline Plc., Johnson & Johnson and others.

Segment Analysis

Market Research Future report offers an all-inclusive segmental analysis of the antipsychotic drugs market on the basis of application and generation.

Based on therapeutic application, it is segmented into injectable antipsychotics dementia, depression, bipolar disorder, schizophrenia and others. Of these, psychotic depression and schizophrenia will have the largest share in the antipsychotic drugs market over the predicted years.

Based on generation, the antipsychotic drugs market is segmented into first, second, third. The first generation is also called neuroleptics or typical antipsychotics and the second generation is also called atypical antipsychotics.

Regional Analysis

Based on region, the antipsychotic drugs market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, the American region will have precedence in the market over the predicted years owing to excellent support from the government, better regulatory framework, well-established healthcare infrastructure, good reimbursement scenario especially in the US and rapid uptake of novel drug molecules. Europe will grab the second largest share in the antipsychotic drugs market owing to increasing healthcare expenditure made by the government coupled with increasing disposable income. The antipsychotic drugs market in the Asia Pacific region will grow at the fastest rate and at a healthy CAGR owing to increasing social awareness concerning psychotic disorders and also other associated disorders namely depression, anxiety and mania. Moreover, the accessibility of medicines to treat mental illness will boost the growth of the antipsychotic drugs market in this region over the predicted years.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com